Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDate | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
02/23/2022 | Q4 2021 | -$2.26 | -$2.55 | -0.29 | $54,000 | |
11/04/2021 | Q3 2021 | -$2.53 | -$3.21 | -0.68 | $0 | |
08/05/2021 | Q2 2021 | -$2.20 | -$2.40 | -0.2 | $0 | |
05/05/2021 | Q1 2021 | -$2.16 | -$1.98 | 0.18 | $0 | |
02/23/2021 | Q4 2020 | -$1.85 | -$2.10 | -0.25 | $37,000 | |
11/09/2020 | Q3 2020 | -$1.87 | -$1.69 | 0.18 | $20,000 | |
08/05/2020 | Q2 2020 | -$2.03 | -$1.61 | 0.42 | $0 | |
05/07/2020 | Q1 2020 | -$2.28 | -$2.00 | 0.28 | $262,000 | |
02/27/2020 | Q4 2019 | -$1.76 | $3.00 M | |||
11/08/2019 | Q3 2019 | -$1.46 | $1.35 M | |||
08/08/2019 | Q2 2019 | -$1.24 | $1.02 M | |||
05/09/2019 | Q1 2019 | $12.53 | $801.06 M | |||
02/28/2019 | Q4 2018 | $1.39 | $8.65 M | |||
11/08/2018 | Q3 2018 | -$0.70 | $3.57 M | |||
08/07/2018 | Q2 2018 | -$0.65 | $3.99 M | |||
05/09/2018 | Q1 2018 | -$0.80 | $1.76 M | |||
03/14/2018 | Q4 2017 | -$0.59 | -$0.35 | 0.24 | $273,000 | |
11/08/2017 | Q3 2017 | -$0.86 | $7.95 M | |||
08/08/2017 | Q2 2017 | -$0.77 | $6.49 M | |||
05/09/2017 | Q1 2017 | -$0.72 | -$0.90 | -0.18 | $6.62 M |
Arena Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, May 4th, 2022 based off last year's report dates.
The conference call for Arena Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Arena Pharmaceuticals, Inc.'s latest earnings report can be read online.
Arena Pharmaceuticals, Inc. (:ARNA) has a recorded annual revenue of $54,000.
Arena Pharmaceuticals, Inc. (:ARNA) has a recorded net income of $54,000. Arena Pharmaceuticals, Inc. has generated $-11.33 earnings per share over the last four quarters.
Arena Pharmaceuticals, Inc. (:ARNA) has a price-to-earnings ratio of -8.82 and price/earnings-to-growth ratio is -0.09.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED